NSUN2 lactylation drives cancer cell resistance to ferroptosis through enhancing GCLC-dependent glutathione synthesis

被引:0
|
作者
Niu, Kaifeng [1 ,2 ]
Chen, Zixiang [1 ,2 ]
Li, Mengge [1 ,2 ,3 ]
Ma, Guannan [4 ]
Deng, Yuchun [1 ,2 ,3 ]
Zhang, Ji [1 ,2 ,3 ]
Wei, Di [1 ,2 ]
Wang, Jiaqi [1 ,2 ,3 ]
Zhao, Yongliang [1 ,2 ,3 ]
机构
[1] China Natl Ctr Bioinformat, Beijing 100101, Peoples R China
[2] Chinese Acad Sci, Beijing Inst Genom, Beijing 100101, Peoples R China
[3] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[4] Key Lab Digital Technol Med Diagnost Zhejiang Prov, Hangzhou 310030, Peoples R China
来源
REDOX BIOLOGY | 2025年 / 79卷
基金
中国国家自然科学基金; 美国国家科学基金会; 北京市自然科学基金;
关键词
NSUN2; Lactylation; RNA; 5-methylcytosine; GCLC; Glutathione synthesis; Ferroptosis;
D O I
10.1016/j.redox.2024.103479
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lactate-mediated lactylation on target proteins is recently identified as the novel posttranslational modification with profound biological functions. RNA 5-methylcytosine (m5C) modification possesses dynamic and reversible nature, suggesting that activity of its methyltransferase NSUN2 is actively regulated. However, how NSUN2 activity is response to acidic condition in tumor microenvironment and then regulates cancer cell survival remain to be clarified. Here, we demonstrate that NSUN2 activity is enhanced by lactate-mediated lactylation at lysine 508, which then targets glutamate-cysteine ligase catalytic subunit (GCLC) mRNA to facilitates GCLC m5C formation and mRNA stabilization. The activated GCLC induces higher level of intracellular GSH accompanied by decreased lipid peroxidation and resistant phenotype to ferroptosis induction by doxorubicin (Dox) in gastric cancer cells. Specifically, the effect of NSUN2 lactylation-GCLC-GSH pathway is nearly lost when NSUN2 K508R or GCLC C-A mutant (five cytosine sites) was introduced into the cancer cells. We further identify the catalytic subunit N-alpha-acetyltransferase 10 (NAA10) as the lactytransferase of NSUN2, and lactate treatment substantially enhances their association and consequent NSUN2 activation. Taken together, our findings convincingly elucidate the signaling axis of NAA10-NSUN2-GCLC that potently antagonizes the ferroptosis under acidic condition, and therefore, targeting NSUN2 lactylation might be an effective strategy in improving the prognosis of cancer patients.
引用
收藏
页数:14
相关论文
共 24 条
  • [21] Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer
    Haricharan, Svasti
    Punturi, Nindo
    Singh, Purba
    Holloway, Kimberly R.
    Anurag, Meenakshi
    Schmelz, Jacob
    Schmidt, Cheryl
    Lei, Jonathan T.
    Suman, Vera
    Hunt, Kelly
    Olson, John A., Jr.
    Hoog, Jeremy
    Li, Shunqiang
    Huang, Shixia
    Edwards, Dean P.
    Kavuri, Shyam M.
    Bainbridge, Matthew N.
    Ma, Cynthia X.
    Ellis, Matthew J.
    CANCER DISCOVERY, 2017, 7 (10) : 1168 - 1183
  • [22] Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF)
    B S Tan
    K H Tiong
    H L Choo
    F Fei-Lei Chung
    L-W Hii
    S H Tan
    I KS Yap
    S Pani
    N TW Khor
    S F Wong
    R Rosli
    S-K Cheong
    C-O Leong
    Cell Death & Disease, 2015, 6 : e1826 - e1826
  • [23] HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism
    Jian Cui
    Fei Xu
    Wei Bai
    Tiantian Zhao
    Junbo Hong
    Wei Zuo
    Journal of Translational Medicine, 21
  • [24] HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism
    Cui, Jian
    Xu, Fei
    Bai, Wei
    Zhao, Tiantian
    Hong, Junbo
    Zuo, Wei
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)